ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,424,000 | +35.2% | 8,274 | -1.4% | 0.08% | +40.4% |
| Q2 2021 | $1,053,000 | -26.1% | 8,389 | -20.1% | 0.06% | -29.6% |
| Q1 2021 | $1,424,000 | +72.8% | 10,503 | +63.1% | 0.08% | +37.3% |
| Q4 2020 | $824,000 | -58.7% | 6,441 | -63.6% | 0.06% | -9.2% |
| Q3 2020 | $1,994,000 | -34.1% | 17,718 | -44.2% | 0.06% | -16.7% |
| Q2 2020 | $3,024,000 | +102.7% | 31,737 | +91.2% | 0.08% | +100.0% |
| Q1 2020 | $1,492,000 | +69.0% | 16,599 | -0.3% | 0.04% | +225.0% |
| Q4 2019 | $883,000 | – | 16,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
| Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
| Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
| Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
| Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
| QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
| Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |